Chronic viral hepatitis in thalassemic liver disease. A long-term study in patients with acute hepatitis with nontransfusion-dependent thalassemia minor

Vox Sang. 1983;44(1):14-24. doi: 10.1111/j.1423-0410.1983.tb04098.x.

Abstract

To evaluate the effective role of hepatitis viruses in thalassemic (Th) liver disease, we carried out a long-term study in 42 subjects with nontransfusion-dependent Th minor hospitalized for an episode of acute viral hepatitis. 10 patients had serologic evidence of hepatitis A, 23 of hepatitis B and 9 of hepatitis non-A, non-B. In the follow-up chronic hepatitis was detected histologically in 5/23 patients with hepatitis B and 5/9 with hepatitis non-A, non-B. All hepatitis A patients recovered completely. The prevalence in 7 out of 10 patients with chronic hepatitis of piecemeal necrosis and of inflammatory changes over hepatic siderosis and fibrosis evidenced a determinant role of chronic viral infection in the development of liver damage in these patients. Thus, heterozygous nontransfusion-dependent Th patients seem to have a high risk of developing a chronic inflammatory liver disease especially after an episode of non-A, non-B hepatitis. Therefore, in our geographical area, chronic hepatitis of viral origin should be taken into account, among other pathogenetic factors, in many cases of cryptogenic thalassemic liver disease.

MeSH terms

  • Acute Disease
  • Blood Transfusion*
  • Hepatitis A / complications
  • Hepatitis B / complications
  • Hepatitis B / pathology
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis C / complications
  • Hepatitis C / drug therapy
  • Hepatitis C / pathology
  • Hepatitis, Chronic / complications*
  • Hepatitis, Chronic / drug therapy
  • Hepatitis, Chronic / pathology
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / pathology
  • Long-Term Care
  • Prednisone / therapeutic use
  • Thalassemia / complications*
  • Thalassemia / therapy

Substances

  • Hepatitis B Surface Antigens
  • Prednisone